Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-007873-22Phase 2Completed
Phase 2 trial of nabilone in medication overuse headache (MOH) and chronic daily headache (CDH) (2 arms), sponsored by AOU Policlinico di Modena. Primary endpoints: Safety and tolerability of nabilone and Reduction in analgesic consumption. Started Dec 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-007873-22.